What does DR.L.SCHREVENS,pneumologie do?

DR.L.SCHREVENS,pneumologie is a training centre in Holsbeek. Private Limited, started on 29 March 2007, 1 establishment.

What is the address of DR.L.SCHREVENS,pneumologie?

The registered office of DR.L.SCHREVENS,pneumologie is located at Houwaartsgat 2, 3221 Holsbeek.

Is DR.L.SCHREVENS,pneumologie still active?

Yes. According to the CBE (29 September 2026) DR.L.SCHREVENS,pneumologie is active, legal situation “Normale toestand”, started on 29 March 2007.

Is DR.L.SCHREVENS,pneumologie registered on Peppol?

Yes, DR.L.SCHREVENS,pneumologie is registered on the Peppol network with ID 0208:0888857322.

What is the enterprise number of DR.L.SCHREVENS,pneumologie?

The enterprise number of DR.L.SCHREVENS,pneumologie is BE0888857322.

When was DR.L.SCHREVENS,pneumologie founded?

DR.L.SCHREVENS,pneumologie was founded on 29 March 2007.

Who are the directors of DR.L.SCHREVENS,pneumologie?

According to the 2025 annual accounts, the directors of DR.L.SCHREVENS,pneumologie are: Liesbet Schrevens.

Is DR.L.SCHREVENS,pneumologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 March 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR.L.SCHREVENS,pneumologie make in 2025?

DR.L.SCHREVENS,pneumologie posted a profit after taxes of € 220,343 in financial year 2025.

What is the revenue of DR.L.SCHREVENS,pneumologie?

As a small company, DR.L.SCHREVENS,pneumologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 323,708.

DR.L.SCHREVENS,pneumologie (Private Limited) - Holsbeek

Dossier DR.L.SCHREVENS,pneumologie, printed on 29 September 2026 from databakkes.be/en/0888857322/dr-l-schrevens-pneumologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR.L.SCHREVENS,pneumologie from Holsbeek, company number BE0888857322, closed financial year 2025 with a result of € 220,343 after tax. For that financial year DR.L.SCHREVENS,pneumologie recorded a gross margin of € 323,708 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 200,102 to € 220,343. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.

What it is worth Growing

€ 1.1 million

▲ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 220,343

▲ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 359,298

▼ 28% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 171,462 paid out

78 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 4,383

▼ 40% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 463

▼ 75% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 32,644

▲ 28% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 286,214 Gross margin 2022: € 286,214 First fiscal year in the series	€ 268,732 Gross margin 2023: € 268,732 ▼ 6% vs 2022 (€ 286,214) Unfavourable step	€ 312,540 Gross margin 2024: € 312,540 ▲ 16% vs 2023 (€ 268,732) Favourable step	€ 323,708 Gross margin 2025: € 323,708 ▲ 4% vs 2024 (€ 312,540) Favourable step	▲ 4%
Profit after taxes	€ 178,663 Profit after taxes 2022: € 178,663 First fiscal year in the series	€ 168,723 Profit after taxes 2023: € 168,723 ▼ 6% vs 2022 (€ 178,663) Unfavourable step	€ 200,102 Profit after taxes 2024: € 200,102 ▲ 19% vs 2023 (€ 168,723) Favourable step	€ 220,343 Profit after taxes 2025: € 220,343 ▲ 10% vs 2024 (€ 200,102) Favourable step	▲ 10%
Equity	€ 987,666 Equity 2022: € 987,666 First fiscal year in the series	€ 1,024,671 Equity 2023: € 1,024,671 ▲ 4% vs 2022 (€ 987,666) Favourable step	€ 1,091,296 Equity 2024: € 1,091,296 ▲ 7% vs 2023 (€ 1,024,671) Favourable step	€ 1,140,177 Equity 2025: € 1,140,177 ▲ 4% vs 2024 (€ 1,091,296) Favourable step	▲ 4%
Total debts	€ 24,044 Total debts 2022: € 24,044 First fiscal year in the series	€ 49,346 Total debts 2023: € 49,346 ▲ 105% vs 2022 (€ 24,044) Unfavourable step	€ 121,341 Total debts 2024: € 121,341 ▲ 146% vs 2023 (€ 49,346) Unfavourable step	€ 36,270 Total debts 2025: € 36,270 ▼ 70% vs 2024 (€ 121,341) Favourable step	▼ 70%
Cash	€ 518,926 Cash 2022: € 518,926 First fiscal year in the series	€ 476,864 Cash 2023: € 476,864 ▼ 8% vs 2022 (€ 518,926) Unfavourable step	€ 501,294 Cash 2024: € 501,294 ▲ 5% vs 2023 (€ 476,864) Favourable step	€ 359,298 Cash 2025: € 359,298 ▼ 28% vs 2024 (€ 501,294) Unfavourable step	▼ 28%
Land & buildings	€ 371,976 Land & buildings 2022: € 371,976 First fiscal year in the series	€ 344,964 Land & buildings 2023: € 344,964 ▼ 7% vs 2022 (€ 371,976) Unchanged	€ 317,952 Land & buildings 2024: € 317,952 ▼ 8% vs 2023 (€ 344,964) Unchanged	€ 292,404 Land & buildings 2025: € 292,404 ▼ 8% vs 2024 (€ 317,952) Unchanged	▼ 8%
Retained profit	€ 975,266 Retained profit 2022: € 975,266 First fiscal year in the series	€ 1,012,271 Retained profit 2023: € 1,012,271 ▲ 4% vs 2022 (€ 975,266) Favourable step	€ 1,078,896 Retained profit 2024: € 1,078,896 ▲ 7% vs 2023 (€ 1,012,271) Favourable step	€ 1,127,777 Retained profit 2025: € 1,127,777 ▲ 5% vs 2024 (€ 1,078,896) Favourable step	▲ 5%
Dividend	€ 96,114 Dividend 2022: € 96,114 First fiscal year in the series	€ 131,718 Dividend 2023: € 131,718 ▲ 37% vs 2022 (€ 96,114) Unchanged	€ 133,477 Dividend 2024: € 133,477 ▲ 1% vs 2023 (€ 131,718) Unchanged	€ 171,462 Dividend 2025: € 171,462 ▲ 28% vs 2024 (€ 133,477) Unchanged	▲ 28%
Balance sheet total	€ 1,011,710 Balance sheet total 2022: € 1,011,710 First fiscal year in the series	€ 1,074,017 Balance sheet total 2023: € 1,074,017 ▲ 6% vs 2022 (€ 1,011,710) Unchanged	€ 1,212,637 Balance sheet total 2024: € 1,212,637 ▲ 13% vs 2023 (€ 1,074,017) Unchanged	€ 1,176,447 Balance sheet total 2025: € 1,176,447 ▼ 3% vs 2024 (€ 1,212,637) Unchanged	▼ 3%

Key figures of DR.L.SCHREVENS,pneumologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR.L.SCHREVENS,pneumologie?

What happened at DR.L.SCHREVENS,pneumologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 15, 2026 New annual accounts for financial year 2025: profit of € 220,343 (▲ 10% vs 2024). Source: NBB ↗
Apr 18, 2007 New establishment in Holsbeek. KBO
Mar 29, 2007 Start of the company according to the CBE. KBO

In short

From € 178,663 profit in 2022 to € 220,343 profit in 2025.

Paid € 336,884 in corporate taxes since 2022.

Best year ever: 2025, with € 220,343 profit.

Paid out € 532,772 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR.L.SCHREVENS,pneumologie? We notify you, reason included.

Follow DR.L.SCHREVENS,pneumologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Liesbet Schrevens

DR.L.SCHREVENS,pneumologie

Behind DR.L.SCHREVENS,pneumologie is Liesbet Schrevens.

See the full network in the app

Directors

According to the 2025 annual accounts

Liesbet Schrevens

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Houwaartsgat 2

3221 Holsbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0888.857.322

VAT number

BE 0888.857.322

Registered office

Houwaartsgat 2, 3221 Holsbeek

Names & denominations

DR.L.SCHREVENS,pneumologie

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

29 March 2007

Peppol

Active · Active since 2 Jan 2026

Activities · NACE

Sociaal-cultureel vormingswerk

Overige vormen van onderwijs

View on CBE Public ↗ Annual accounts (NBB) ↗

DR.L.SCHREVENS,pneumologie

Financials

What happened to DR.L.SCHREVENS,pneumologie?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions